Cargando…
Dual-mechanistic antibody-drug conjugate via site-specific selenocysteine/cysteine conjugation
BACKGROUND: While all clinically translated antibody-drug conjugates (ADCs) contain a single-drug payload, most systemic cancer chemotherapies involve use of a combination of drugs. These regimens improve treatment outcomes and slow development of drug resistance. We here report the generation of an...
Autores principales: | Nilchan, Napon, Li, Xiuling, Pedzisa, Lee, Nanna, Alex R, Roush, William R, Rader, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953743/ https://www.ncbi.nlm.nih.gov/pubmed/31930187 http://dx.doi.org/10.1093/abt/tbz009 |
Ejemplares similares
-
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates
por: Nanna, Alex R., et al.
Publicado: (2017) -
Improving the Serum Stability of Site-Specific Antibody
Conjugates with Sulfone Linkers
por: Patterson, James T., et al.
Publicado: (2014) -
In Vitro and In Vivo Evaluation of Cysteine and Site Specific Conjugated Herceptin Antibody-Drug Conjugates
por: Jackson, Dowdy, et al.
Publicado: (2014) -
Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues
por: Zhou, Qun, et al.
Publicado: (2021) -
Site-Specific Antibody–Drug Conjugates in Triple Variable Domain Fab Format
por: Hwang, Dobeen, et al.
Publicado: (2020)